Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Combination Biologic Therapy as Initial Treatment for Follicular Lymphoma: Initial Results From CALGB 50701 - a Phase II Trial of Extended Induction Epratuzumab (anti-CD22) and Rituximab (anti-CD20)

Barbara Grant, MD, John P. Leonard, MD, Jeffrey L Johnson, Lale Kostakoglu, Eric Hsi, MD, John C. Byrd, MD, Jeffrey A. Jones, MD, MPH, Sin-Ho Jung, Bruce D. Cheson, MD

Blood (2010) 116 (21): 427.

https://doi.org/10.1182/blood.V116.21.427.427

Published: 2010

Journal Articles

Alternative Splicing Is a Major Mechanism of Gene Regulation In Diffuse Large B Cell Lymphoma

Blood (2010) 116 (21): 803.

https://doi.org/10.1182/blood.V116.21.803.803

Published: 2010

Journal Articles

Expression of Phosphorylated Signal Transducer and Activator of Transcription 5 (pSTAT5) Is Associated with An Increased Risk of Death In Acute Myeloid Leukemia.

Anna Brady, MD, Sarah Gibson, MD, Lisa Rybicki, MS, Eric Hsi, MD, Edward Copelan, MD, Matt Kalaycio, MD, Mikkael A. Sekeres, MD, MS, Ronald Sobecks, MD, Yogen Saunthararajah, MD, Jennifer Bates, Anjali S. Advani, MD

Blood (2010) 116 (21): 1675.

https://doi.org/10.1182/blood.V116.21.1675.1675

Published: 2010

Journal Articles

CBL, CBLB, TET2, ASXL1 , and IDH1/2 Mutations as Well as Additional Chromosomal Aberrations Constitute Molecular Events Contributing to Malignant Progression In Advanced Philadelphia Chromosome-Positive Disorders.

Hideki Makishima, MD, PhD, Anna Jankowska, MSC, Michael A McDevitt, MD, PhD, Simon Dujardin, Heather Cazzolli, Bartlomiej Przychodzen, Courtney Prince, John Nicoll, Siddaiah Harish, MD, Mohammed Shaik, MD, Eric Hsi, MD, Anjali Advani, MD, Ronald Paquette, MD, Jaroslaw P Maciejewski, MD, PhD, FACP

Blood (2010) 116 (21): 3396.

https://doi.org/10.1182/blood.V116.21.3396.3396

Published: 2010

Journal Articles

Inter-Reader Variability In Identifying Centroblast Cells From Digital Follicular Lymphoma Cases

Kamel Belkacem-Boussaid, Michael Pennell, Arwa Shana' Ah, Amy Gerwitz, Weiqiang Zhao, Frederick Racke, MD, PhD, Eric Hsi, MD, Gerard Lozanski, MD, Metin Gurcan

Blood (2010) 116 (21): 5095.

https://doi.org/10.1182/blood.V116.21.5095.5095

Published: 2010

Journal Articles

Intra-Reader Variability In Identifying Centroblast Cells From Digital Follicular Lymphoma Cases

Kamel Belkacem-Boussaid, Michael Pennell, Ah Arwa Shana', Amy Gerwitz, Weiqiang Zhao, Frederick Racke, MD, PhD, Eric Hsi, MD, Gerard Lozanski, MD, Metin Gurcan

Blood (2010) 116 (21): 5097.

https://doi.org/10.1182/blood.V116.21.5097.5097

Published: 2010

Journal Articles

Mutational Spectrum In Chronic Myelomonocytic Leukemia Includes Genes Associated with Epigenetic Regulation Such as UTX and EZH2

Anna Jankowska, MSc, Hideki Makishima, MD, PhD, Ramon V. Tiu, MD, Hadrian Szpurka, PhD, MSc, Yun Huang, Yuka Sugimoto, MD, PhD, Courtney Prince, BS, Christine L. O'Keefe, PhD, Eric Hsi, MD, Alan F. List, Mikkael A. Sekeres, MD, MS, Anjana Rao, PhD, Michael A McDevitt, MD, PhD, Jaroslaw P Maciejewski, MD, PhD, FACP

Blood (2010) 116 (21): 611.

https://doi.org/10.1182/blood.V116.21.611.611

Published: 2010

Journal Articles

Single Nucleotide Polymorphism Array (SNP-A) Genomic Profiling of Mantle Cell Lymphoma (MCL) Against a Large Control Database Reveals Recurring Copy Number Alterations (CNAs) and Copy Neutral Loss of Heterozygosity (CN-LOH)

Michael J. Rauh, MD, PhD, Juraj Bodo, MD, Eric Hsi, MD, Bill Richendollar, Yuka Sugimoto, MD, PhD, Jaroslaw P Maciejewski, MD, PhD, FACP, Christine L. O'Keefe, PhD, Stephen D. Smith, MD

Blood (2010) 116 (21): 2001.

https://doi.org/10.1182/blood.V116.21.2001.2001

Published: 2010

Journal Articles

CD37 Is a Potential Therapeutic Target for B-Cell Non-Hodgkin Lymphoma

Xiaoxian Zhao, PhD., Suzanne Ybarra, Lisa Durkin, Mien Sho, Neeraj Kumar, Brian Gordon, Paul Algate, Gary Starling, PhD, Debra Chao, Ph.D., Eric Hsi, MD

Blood (2010) 116 (21): 3098.

https://doi.org/10.1182/blood.V116.21.3098.3098

Published: 2010

Journal Articles

Prognostic Significance of Histone (H4) Acetylation In Newly Diagnosed Acute Myeloid Leukemia (AML) Patients with Intermediate Risk Cytogenetics

Mazyar Shadman, MD, MPH, Sarah Gibson, MD, Claudiu Cotta, MD, Yogen Saunthararajah, MD, Eric Hsi, MD, Edward Copelan, MD, Matt Kalaycio, MD, Mikkael A. Sekeres, MD, MS, Ronald Sobecks, MD, Meagan Effinger, BA, Anjali S. Advani, MD

Blood (2010) 116 (21): 2736.

https://doi.org/10.1182/blood.V116.21.2736.2736

Published: 2010

Journal Articles

High Rate of Survival in Transformed Lymphoma after Autologous Stem Cell Transplant (ASCT): Pathologic Analysis and Comparison with De Novo DLBCL.

Stephen S. Smith, MD, Brian Bolwell, MD, Anjali Advani, MD, Steven Andresen, DO, Josephine Chan, Robert Dean, MD, Eric Hsi, MD, Matt Kalaycio, MD, Brad Pohlman, MD, Lisa Rybicki, MS, Ronald Sobecks, MD, John Sweetenham, MD

Blood (2008) 112 (11): 1137.

https://doi.org/10.1182/blood.V112.11.1137.1137

Published: 2008

Journal Articles

Elotuzumab (HuLuc63) Activates CD56 dim Natural Killer Cells and Monocytes Resulting in the Release of IP-10 and MCP-1

Balaji Balasa, PhD, Mahrukh Huseni, MSc, Jyothi Cherukuri, MSc, Roxanne Steinle, BSc, Amulya Nanisetti, MSc, Daniel Afar, PhD, Eric Hsi, MD, Vladimir Vexler, PhD

Blood (2008) 112 (11): 108.

https://doi.org/10.1182/blood.V112.11.108.108

Published: 2008

Journal Articles

FLIPI Score Is Applicable and Predictive of Response to Upfront Immunotherapy in CALGB 50402: Phase II Trial of Extended Induction Galiximab ([G] anti-CD80 monoclonal antibody) Plus Rituximab [R].

Myron S. Czuczman, MD, John P. Leonard, MD, Jeffrey L Johnson, Sin- Ho Jung, Eric Hsi, MD, John C. Byrd, MD, Bruce D. Cheson, MD

Blood (2008) 112 (11): 1003.

https://doi.org/10.1182/blood.V112.11.1003.1003

Published: 2008

Journal Articles

Potent Anti-Cancer Activity of Anti-NTB-a Monoclonal Antibodies in Preclinical Leukemia and Lymphoma Models

Wouter Korver, PhD, Xiaoxian Zhao, Shweta Singh, Cecile Pardoux, Ishita Barman, Gerard Aguilar, Jingsong Zhao, Eric Hsi, MD, Arie Abo

Blood (2008) 112 (11): 4975.

https://doi.org/10.1182/blood.V112.11.4975.4975

Published: 2008

Journal Articles

A Phase 1 Trial of Imatinib Mesylate with Daunorubicin and Cytarabine for Patients with C-Kit Positive Relapsed AML.

Anjali Advani, MD, Edward A. Copelan, MD, Ronald Sobecks, MD, Mikkael A Sekeres, MD, MS, Jennifer Bates, Mary Lynn Rush, Barbara Tripp, Elysa Noon, PhD, Matthew Howard, MD, Tao Jin, Eric Hsi, MD, Matt Kalaycio, MD

Blood (2008) 112 (11): 955.

https://doi.org/10.1182/blood.V112.11.955.955

Published: 2008

Journal Articles

Histone H4 Acetylation as a Prognostic Factor for Patients with Acute Lymphocytic Leukemia in First Relapse.

Anjali Advani, MD, Sarah Gibson, MD, Elizabeth Douglas, MD, Tao Jin, Matt Kalaycio, MD, Edward A. Copelan, MD, Mikkael A Sekeres, MD, MS, Ronald Sobecks, MD, Shawnda Sungren, Eric Hsi, MD

Blood (2008) 112 (11): 1482.

https://doi.org/10.1182/blood.V112.11.1482.1482

Published: 2008

Journal Articles

OCT-2 Expression and OCT-2/BOB.1 Co-Expression Predict Prognosis in Patients with Newly Diagnosed Acute Myelogenous Leukemia.

Kathleen Lim, MD, Sarah Gibson, MD, Tao Jin, Eric Hsi, MD, Matt Kalaycio, MD, Edward A. Copelan, MD, Mikkael A. Sekeres, MD, MS, Ronald Sobecks, MD, Anjali Advani, MD

Blood (2008) 112 (11): 1486.

https://doi.org/10.1182/blood.V112.11.1486.1486

Published: 2008

Journal Articles

Prognostic Value of Tumor-Infiltrating TIA-1+ Cytotoxic T Cells (TIA1-CTCs) and FOXP3+ Regulatory T Cells (Tregs) in Post-Transplant Lymphoproliferative Disorder (PTLD) Following Solid Organ Transplant (SOT).

Raymond E. Tsao, MD, Bill Richendollar, MD, Tony Jin, Eric Hsi, MD, Brad Pohlman, MD

Blood (2007) 110 (11): 54.

https://doi.org/10.1182/blood.V110.11.54.54

Published: 2007

Journal Articles

CD117 Expression Is a Poor Prognostic Factor (PF) for Progression Free Survival (PFS) and Freedom from Progression (FFP) in Patients with Newly Diagnosed Acute Myelogenous Leukemia (AML).

Wael Saber, MD, Rony Abou-Jawde, MD, Eric Hsi, MD, Tao Jin, MS, Matt Kalaycio, MD, Ronald Sobecks, MD, Mikkael Sekeres, MD, Brad Pohlman, MD, Barbara L. Tripp, RN, Anjali Advani, MD

Blood (2005) 106 (11): 3292.

https://doi.org/10.1182/blood.V106.11.3292.3292

Published: 2005

Journal Articles

Splenectomy for Splenic Marginal B-Cell Lymphoma.

Ena Segota, MD, Philip Shaheen, MD, Eric Hsi, MD, Matt Kalaycio, MD

Blood (2005) 106 (11): 3339.

https://doi.org/10.1182/blood.V106.11.3339.3339

Published: 2005

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Combination Biologic Therapy as Initial Treatment for Follicular Lymphoma: Initial Results From CALGB 50701 - a Phase II Trial of Extended Induction Epratuzumab (anti-CD22) and Rituximab (anti-CD20)

Alternative Splicing Is a Major Mechanism of Gene Regulation In Diffuse Large B Cell Lymphoma

Expression of Phosphorylated Signal Transducer and Activator of Transcription 5 (pSTAT5) Is Associated with An Increased Risk of Death In Acute Myeloid Leukemia.

CBL, CBLB, TET2, ASXL1 , and IDH1/2 Mutations as Well as Additional Chromosomal Aberrations Constitute Molecular Events Contributing to Malignant Progression In Advanced Philadelphia Chromosome-Positive Disorders.

Inter-Reader Variability In Identifying Centroblast Cells From Digital Follicular Lymphoma Cases

Intra-Reader Variability In Identifying Centroblast Cells From Digital Follicular Lymphoma Cases

Mutational Spectrum In Chronic Myelomonocytic Leukemia Includes Genes Associated with Epigenetic Regulation Such as UTX and EZH2

Single Nucleotide Polymorphism Array (SNP-A) Genomic Profiling of Mantle Cell Lymphoma (MCL) Against a Large Control Database Reveals Recurring Copy Number Alterations (CNAs) and Copy Neutral Loss of Heterozygosity (CN-LOH)

CD37 Is a Potential Therapeutic Target for B-Cell Non-Hodgkin Lymphoma

Prognostic Significance of Histone (H4) Acetylation In Newly Diagnosed Acute Myeloid Leukemia (AML) Patients with Intermediate Risk Cytogenetics

High Rate of Survival in Transformed Lymphoma after Autologous Stem Cell Transplant (ASCT): Pathologic Analysis and Comparison with De Novo DLBCL.

Elotuzumab (HuLuc63) Activates CD56 dim Natural Killer Cells and Monocytes Resulting in the Release of IP-10 and MCP-1

FLIPI Score Is Applicable and Predictive of Response to Upfront Immunotherapy in CALGB 50402: Phase II Trial of Extended Induction Galiximab ([G] anti-CD80 monoclonal antibody) Plus Rituximab [R].

Potent Anti-Cancer Activity of Anti-NTB-a Monoclonal Antibodies in Preclinical Leukemia and Lymphoma Models

A Phase 1 Trial of Imatinib Mesylate with Daunorubicin and Cytarabine for Patients with C-Kit Positive Relapsed AML.

Histone H4 Acetylation as a Prognostic Factor for Patients with Acute Lymphocytic Leukemia in First Relapse.

OCT-2 Expression and OCT-2/BOB.1 Co-Expression Predict Prognosis in Patients with Newly Diagnosed Acute Myelogenous Leukemia.

Prognostic Value of Tumor-Infiltrating TIA-1+ Cytotoxic T Cells (TIA1-CTCs) and FOXP3+ Regulatory T Cells (Tregs) in Post-Transplant Lymphoproliferative Disorder (PTLD) Following Solid Organ Transplant (SOT).

CD117 Expression Is a Poor Prognostic Factor (PF) for Progression Free Survival (PFS) and Freedom from Progression (FFP) in Patients with Newly Diagnosed Acute Myelogenous Leukemia (AML).

Splenectomy for Splenic Marginal B-Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology